175 related articles for article (PubMed ID: 27694828)
21. SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis.
Wang Y; Zhou D; Phung S; Warden C; Rashid R; Chan N; Chen S
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1500-E1508. PubMed ID: 28174265
[TBL] [Abstract][Full Text] [Related]
22. Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells.
Mahalingaiah PK; Ponnusamy L; Singh KP
Breast Cancer Res Treat; 2015 Aug; 153(1):41-56. PubMed ID: 26208486
[TBL] [Abstract][Full Text] [Related]
23. Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
Padua MB; Bhat-Nakshatri P; Anjanappa M; Prasad MS; Hao Y; Rao X; Liu S; Wan J; Liu Y; McElyea K; Jacobsen M; Sandusky G; Althouse S; Perkins S; Nakshatri H
Breast Cancer Res; 2018 May; 20(1):35. PubMed ID: 29720215
[TBL] [Abstract][Full Text] [Related]
24. Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells.
Padró M; Louie RJ; Lananna BV; Krieg AJ; Timmerman LA; Chan DA
BMC Cancer; 2017 Mar; 17(1):203. PubMed ID: 28320353
[TBL] [Abstract][Full Text] [Related]
25. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
26. miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer.
Kim YS; Park SJ; Lee YS; Kong HK; Park JH
Oncotarget; 2016 Jul; 7(27):42261-42273. PubMed ID: 27304060
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.
Li Y; Jiang B; Wu X; Huang Q; Chen W; Zhu H; Qu X; Xie L; Ma X; Huang G
Biochem Biophys Res Commun; 2018 Sep; 503(1):45-50. PubMed ID: 29792859
[TBL] [Abstract][Full Text] [Related]
29. The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells.
Piccolella M; Crippa V; Cristofani R; Rusmini P; Galbiati M; Cicardi ME; Meroni M; Ferri N; Morelli FF; Carra S; Messi E; Poletti A
Oncotarget; 2017 Feb; 8(6):10400-10415. PubMed ID: 28060751
[TBL] [Abstract][Full Text] [Related]
30. Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells.
Linher-Melville K; Zantinge S; Singh G
Biochem Biophys Res Commun; 2012 Jan; 417(3):1063-8. PubMed ID: 22226967
[TBL] [Abstract][Full Text] [Related]
31. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
32. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
[TBL] [Abstract][Full Text] [Related]
33. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
[TBL] [Abstract][Full Text] [Related]
34. Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy.
Fukui F; Hayashi SI; Yamaguchi Y
J Steroid Biochem Mol Biol; 2020 Jul; 201():105698. PubMed ID: 32404282
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.
Choschzick M; Lebeau A; Marx AH; Tharun L; Terracciano L; Heilenkötter U; Jaenicke F; Bokemeyer C; Simon R; Sauter G; Schwarz J
Hum Pathol; 2010 Mar; 41(3):358-65. PubMed ID: 19896697
[TBL] [Abstract][Full Text] [Related]
36. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
Felzen V; Hiebel C; Koziollek-Drechsler I; Reißig S; Wolfrum U; Kögel D; Brandts C; Behl C; Morawe T
Cell Death Dis; 2015 Jul; 6(7):e1812. PubMed ID: 26158518
[TBL] [Abstract][Full Text] [Related]
38. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
[TBL] [Abstract][Full Text] [Related]
39. RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferation.
Liu Z; Zhang J; Xu J; Yang H; Li X; Hou Y; Zhao Y; Xue M; Wang B; Yu N; Yu S; Niu G; Wu G; Li X; Wang H; Zhu J; Zhuang T
J Cell Mol Med; 2018 Sep; 22(9):4161-4170. PubMed ID: 29974997
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]